Needham & Company
-
Flexion Therapeutics to Present at the Needham Virtual Epilepsy and Pain Specialty CNS Therapeutics Conference
-
Flexion Therapeutics (FLXN) Prices 9.23M Share Common Offering at $9.75/Sh
-
Flexion Therapeutics Announces Pricing of Public Offering of Common Stock
-
Flexion Therapeutics to Present at the 19th Annual Needham Virtual Healthcare Conference
-
Needham & Company Reiterates $36 PT on Flexion Therapeutics (FLXN)
-
Companies with NDRs 11/20
-
Flexion Therapeutics to Present at the 18th Annual Needham & Company Healthcare Conference
-
Pre-Open Movers 04/19 (BPTH) (GWW) (AMZN) Higher; (ACET) (HMNY) (SNBR) (PIR) Lower (more...)
-
Flexion Therapeutics to Present at Needham & Company's 17th Annual Healthcare Conference
-
Pre-Open Movers 12/14: (TEVA) (BAND) (NSDS) Higher; (PIR) (TNTR) (ABM) Lower (more...)
-
Flexion Therapeutics (FLXN) Prices 4.8M Shares at $25.50
-
Flexion Therapeutics Announces Pricing of Public Offering of Common Stock
-
Flexion Therapeutics (FLXN) PT Raised to $42 at Needham & Company on 'FDA Approval for Zilretta with Comprehensive Label'
-
Flexion Therapeutics (FLXN) PT Raised to $36 at Needham & Company
-
Needham & Company Reiterates Buy on Flexion Therapeutics (FLXN) Following Investor Meetings
-
Flexion Therapeutics to Present at Needham & Company’s 16th Annual Healthcare Conference
-
Needham & Company Raises Price Target on Flexion Therapeutics (FLXN) to $34
-
Flexion Therapeutics to Present at 15th Annual Needham Healthcare Conference
-
Needham & Company Keeps Flexion Therapeutics (FLXN) at 'Buy' as Zilretta Conversation Shifts to Commercial Viability
-
Needham & Company Cuts Price Target on Flexion Therapeutics (FLXN) Following Top-Line FX006 Data
-
Flexion Therapeutics to Present at 14th Annual Needham Healthcare Conference
-
Flexion Therapeutics (FLXN) Prices Larger 5.04M Common Offering at $17/Share
-
Flexion Therapeutics (FLXN) Announces 3.5M Common Offering
-
Flexion Therapeutics (FLXN) PT Lifted to $31 at Needham & Company on Matter Patent
-
Needham & Company Starts Flexion Therapeutics (FLXN) at Buy
-
Flexion Therapeutics (FLXN) IPO Ramps 20% Higher

